Ginkgo Bioworks (NYSE:DNA) Shares Gap Down – What’s Next?

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) gapped down before the market opened on Monday . The stock had previously closed at $13.36, but opened at $12.37. Ginkgo Bioworks shares last traded at $12.08, with a volume of 301,887 shares.

Ginkgo Bioworks Trading Up 11.4 %

The business has a fifty day moving average price of $10.57.

Hedge Funds Weigh In On Ginkgo Bioworks

Hedge funds have recently made changes to their positions in the business. KBC Group NV bought a new position in Ginkgo Bioworks during the fourth quarter worth about $31,000. Bank of New York Mellon Corp lifted its position in shares of Ginkgo Bioworks by 48.2% in the fourth quarter. Bank of New York Mellon Corp now owns 23,061 shares of the company’s stock valued at $226,000 after buying an additional 7,503 shares during the last quarter. Palumbo Wealth Management LLC bought a new position in shares of Ginkgo Bioworks during the 4th quarter worth approximately $144,000. Y Intercept Hong Kong Ltd acquired a new position in shares of Ginkgo Bioworks during the 4th quarter worth approximately $154,000. Finally, SG Americas Securities LLC bought a new stake in Ginkgo Bioworks in the 4th quarter valued at $199,000. 78.63% of the stock is owned by institutional investors.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.